Von Hippel-Lindau (VHL) disease frequently leads to VHL-associated renal cell carcinoma (RCC), which carries a poor prognosis.

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

Two prominent Black physicians urge Black people and other people of color to discard long-repeated misinformation related to ...

The Silicon Review explores how skipping routine dental checkups can lead to costly treatments, poor health outcomes, and ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

Women with advanced breast cancer who undergo breast cancer surgery may live longer than those who don't have surgery, a new ...

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to ...

During a live event, Nelson J. Chao, MD, asked participants how they employ the currently approved treatments for chronic GVHD.

We consulted dentists to discover the potential benefits and side effects of fluoride-free, nano-hydroxyapatite toothpaste.

Most patients demonstrated at least partial response to tarlatamab in a real-world population with extensive-stage small cell ...

Antonis Zampelas, chairman of the Board of Directors of EFET, writes about the country's fragmented food policy and how much it harms the health of citizens and the National Health System ...